Hemodialysis International · 2016 · 12 citations · 5 references
MedicineNeurologyPharmacologyClinical PharmacologyDiabetologyNeuropharmacologyDiabetic NeuropathyGabaergic Pharmacology
Gabapentin is commonly used for controlling convulsions, restless pain syndrome, and pain in diabetic neuropathy. Common side effects include dizziness, somnolence, ataxia, peripheral edema, and confusion; gabapentin-induced rhabdomyolysis is rarely reported. To date, the reported cases of gabapentin-induced rhabdomyolysis have been associated with patients with multiple underlying diseases and assuming multiple medicines for various reasons. In this report, we describe a case of gabapentin-induced rhabdomyolysis in a 32-year-old woman with no medical history. We also review related literature and discuss the possible mechanism and the association with other factors. This case shows that gabapentin can induce rhabdomyolysis in healthy patients and that clinicians must consider the possible association between gabapentin and rhabdomyolysis.
5
A method for estimating the probability of adverse drug reactions
C. A. Naranjo, U. Busto, Edward M. Sellers et al. · Clinical Pharmacology & Therapeutics · 1981 · 11.6K citations
Gabapentin-Induced Severe Myopathy
Marco Tuccori, Giuseppe A. G. Lombardo, Francesco Lapi et al. · Annals of Pharmacotherapy · 2007 · 38 citations
Gabapentin-Induced Rhabdomyolysis in a Patient with Diabetic Neuropathy
Oktay Bilgir, Mehmet Çalan, Ferda Bilgir et al. · Internal Medicine · 2009 · 17 citations · Full text